Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APhIRI II alkaline phosphatase in deceased donor kidney transplantation
NL-OMON60783Phase 2Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemia-reperfusion injury (IRI) and delayed graft function (DGF) comparing Bovine alkaline phosphatase with Placebo (2 arms). Primary endpoint: Duration of delayed graft function. Started May 2023; status: recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
ischemia-reperfusion injury (IRI)delayed graft function (DGF)
Beyond the preview
Go deeper on NL-OMON60783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60783.